These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 7570985)

  • 1. Rapamycin inhibits transplant vasculopathy in long-surviving rat heart allografts.
    Schmid C; Heemann U; Azuma H; Tilney NL
    Transplantation; 1995 Oct; 60(7):729-33. PubMed ID: 7570985
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Retransplantation reverses mononuclear infiltration but not myointimal proliferation in a rat model of chronic cardiac allograft rejection.
    Schmid C; Heemann U; Tilney NL
    Transplantation; 1996 Jun; 61(12):1695-9. PubMed ID: 8685945
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Obliterative airway disease after heterotopic tracheal xenotransplantation: pathogenesis and prevention using new immunosuppressive agents.
    Reichenspurner H; Soni V; Nitschke M; Berry GJ; Brazelton TR; Shorthouse R; Huang X; Reitz BA; Morris RE
    Transplantation; 1997 Aug; 64(3):373-83. PubMed ID: 9275099
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Abrogation by rapamycin of accelerated rejection in sensitized rats by inhibition of alloantibody responses and selective suppression of intragraft mononuclear and endothelial cell activation, cytokine production, and cell adhesion.
    Schmidbauer G; Hancock WW; Wasowska B; Badger AM; Kupiec-Weglinski JW
    Transplantation; 1994 Mar; 57(6):933-41. PubMed ID: 8154043
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Factors contributing to the development of chronic rejection in heterotopic rat heart transplantation.
    Schmid C; Heemann U; Tilney NL
    Transplantation; 1997 Jul; 64(2):222-8. PubMed ID: 9256177
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytokine and alloantibody networks in long term cardiac allografts in rat recipients treated with rapamycin.
    Wasowska B; Wieder KJ; Hancock WW; Zheng XX; Berse B; Binder J; Strom TB; Kupiec-Weglinski JW
    J Immunol; 1996 Jan; 156(1):395-404. PubMed ID: 8598490
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rapamycin reverses chronic graft vascular disease in a novel cardiac allograft model.
    Poston RS; Billingham M; Hoyt EG; Pollard J; Shorthouse R; Morris RE; Robbins RC
    Circulation; 1999 Jul; 100(1):67-74. PubMed ID: 10393683
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of endothelin-1 improves survival and vasculopathy in rat cardiac transplants treated with cyclosporine.
    Simonson MS; Robinson AV; Schulak JA; Hricik DE
    Transplantation; 2002 Apr; 73(7):1054-9. PubMed ID: 11965031
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of rapamycin and FK 506 in prolonging rat hind limb allograft survival.
    Fealy MJ; Umansky WS; Bickel KD; Nino JJ; Morris RE; Press BH
    Ann Surg; 1994 Jan; 219(1):88-93. PubMed ID: 7507657
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of functional renal allograft tolerance with single-dose rapamycin based induction immunosuppression.
    Goggins WC; Fisher RA; Dattilo JB; Cohen DS; Tawes JW; Dattilo MP; Babcock GF; Frede SE; Wakely PE; Posner MP
    Transplantation; 1997 Jan; 63(2):310-4. PubMed ID: 9020336
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of rapamycin, RS 61443, cyclosporine, and low-dose heparin as treatment for transplant vasculopathy in a rat model of chronic allograft rejection.
    Schmid C; Heemann U; Azuma H; Tilney NL
    Transplant Proc; 1995 Feb; 27(1):438-9. PubMed ID: 7879053
    [No Abstract]   [Full Text] [Related]  

  • 12. Beneficial effect of graft perfusion with anti-T cell receptor monoclonal antibodies on survival of small bowel allografts in rat recipients treated with brequinar alone or in combination with cyclosporine and sirolimus.
    Wang M; Qu X; Stepkowski SM; Chou TC; Kahan BD
    Transplantation; 1996 Feb; 61(3):458-64. PubMed ID: 8610361
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of graft coronary arteriosclerosis after heart transplantation.
    Soukiasian HJ; Czer LS; Wang HM; Luthringer D; Wang C; Kamlot A; Quartel A; Trento A
    Am Surg; 2004 Oct; 70(10):833-40. PubMed ID: 15529833
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intrasplenic liver parenchymal cells in conjunction with low-dose rapamycin and cyclosporine induce a unique and specific prolongation of rat cardiac and small bowel allograft survival.
    Boyle MJ; Baghdassarian V; Stepkowski SM; Dumble LJ; Kahan BD
    Cell Transplant; 1998; 7(3):247-56. PubMed ID: 9647434
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adjunctive rapamycin and CsA treatment inhibits monocyte/macrophage associated cytokines/chemokines in sensitized cardiac graft recipients.
    Wasowska BA; Zheng XX; Strom TB; Kupieck-Weglinski JW
    Transplantation; 2001 Apr; 71(8):1179-83. PubMed ID: 11374423
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthetic MHC class I peptide prolongs cardiac survival and attenuates transplant arteriosclerosis in the Lewis-->Fischer 344 model of chronic allograft rejection.
    Murphy B; Kim KS; Buelow R; Sayegh MH; Hancock WW
    Transplantation; 1997 Jul; 64(1):14-9. PubMed ID: 9233694
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of cyclosporine A and methotrexate on CD18 expression in recipients of rat cardiac allografts.
    Ciesielski CJ; Mei J; Piccinini LA
    Transpl Immunol; 1998 Jun; 6(2):122-33. PubMed ID: 9777701
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The mechanism of unresponsiveness to allografts induced by rapamycin and rapamycin/cyclosporine treatment in rats.
    Ferraresso M; Ghobrial R; Stepkowski SM; Kahan BD
    Transplantation; 1993 Apr; 55(4):888-94. PubMed ID: 8475565
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rapamycin treatment depresses intragraft expression of KC/MIP-2, granzyme B, and IFN-gamma in rat recipients of cardiac allografts.
    Wieder KJ; Hancock WW; Schmidbauer G; Corpier CL; Wieder I; Kobzik L; Strom TB; Kupiec-Weglinski JW
    J Immunol; 1993 Jul; 151(2):1158-66. PubMed ID: 8335897
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiac allograft atherosclerosis in the rat. The effect of histocompatibility factors, cyclosporine, and an angiotensin-converting enzyme inhibitor.
    Paul LC; Davidoff A; Benediktsson H
    Transplantation; 1994 Jun; 57(12):1767-72. PubMed ID: 7517077
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.